Effect of transcutaneous electrical nerve stimulation on symptomatic diabetic peripheral neuropathy: A meta-analysis of randomized controlled trials



      To evaluate the effectiveness of transcutaneous electrical nerve stimulation (TENS) on diabetic peripheral neuropathy (DPN).


      Randomized controlled trials (RCTs) comparing TENS with routine care, pharmacological interventions or placebo devices on patients with symptomatic DPN, were identified by electronic and manual searches. Studies were selected and available data were extracted independently by two investigators. Meta-analysis was performed by RevMan 4.2.8 software.


      Three RCTs involving 78 patients were included in this study. The reductions in mean pain score were significantly greater in TENS group than in placebo TENS group in 4 weeks and 6 weeks follow-up [4 weeks, SMD-5.37, 95% CI (−6.97, −3.77); 6 weeks, SMD-1.01, 95% CI (−2.01, −0.01)], but not in 12 weeks follow-up [SMD-1.65, 95% CI (−4.02, 0.73)]. TENS therapy was associated with significantly subjective improvement in overall neuropathic symptoms in 12 weeks follow-up [WMD-0.18, 95% CI (−0.32, −0.051)]. No TENS-related adverse events were registered in TENS group.


      TENS therapy may be an effective and safe strategy in treatment of symptomatic DPN. Due to small sample and short-term treatment duration, large multi-centre RCTs are needed to further evaluate the long-term effect of TENS on DPN.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Spruce M.C.
        • Potter J.
        • Coppini D.V.
        The pathogenesis and management of painful diabetic neuropathy: a review.
        Diabet. Med. 2003; 20: 88-98
        • UKPDS Group
        Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
        Lancet. 1998; 352: 837-853
        • Boulton A.J.
        • Knight G.
        • Drury J.
        • Ward J.D.
        The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population.
        Diabetes Care. 1985; 8: 125-128
        • Al-Mahroos F.
        • Al-Roomi K.
        Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study.
        Ann. Saudi Med. 2007; 27: 25-31
        • Gordois A.
        • Scuffham P.
        • Shearer A.
        • Oglesby A.
        • Tobian J.A.
        The health care costs of diabetic peripheral neuropathy in the US.
        Diabetes Care. 2003; 26: 1790-1795
        • McQuay H.J.
        • Moore R.A.
        • Eccleston C.
        • Morley S.
        • Williams A.C.
        Systematic review of outpatient services for chronic pain control.
        Health Technol. Assess. 1997; 1: 1-135
      1. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5.

        • Kumar D.
        • Marshall H.J.
        Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation.
        Diabetes Care. 1997; 20: 1702-1705
        • Kumar D.
        • Alvaro M.S.
        • Julka I.S.
        • Marshall H.J.
        Diabetic peripheral neuropathy: effectiveness of electrotherapy and amitriptyline for symptomatic relief.
        Diabetes Care. 1998; 21: 1322-1325
        • Forst T.
        • Nguyen M.
        • Forst S.
        • Disselhoff B.
        • Pohlmann T.
        • Pfutzner A.
        Impact of low frequency transcutaneous electrical nerve stimulation on symptomatic diabetic neuropathy using the new Salutaris device.
        Diabetes Nutr. Metab. 2004; 17: 163-168
        • Reichstein L.
        • Labrenz S.
        • Ziegler D.
        • Martin S.
        Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation.
        Diabetologia. 2005; 48: 824-828
        • Ivanov K.M.
        • Miasnikova N.V.
        • Ovchinnikova T.I.
        • Sizova T.P.
        • Chemezova T.P.
        The use of transcutaneous electrostimulation in the treatment of diabetic angioneuropathy.
        Vopr Kurortol Fizioter Lech Fiz Kult. 1998; : 30-31
        • Tesfaye S.
        • Watt J.
        • Benbow S.J.
        • Pang K.A.
        • Miles J.
        • MacFarlane I.A.
        Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy.
        Lancet. 1996; 348: 1698-1701
        • Claeys L.G.
        • Horsch S.
        Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
        Int. Angiol. 1996; 15: 344-349
        • Hamza M.A.
        • White P.F.
        • Craig W.F.
        • Ghoname E.S.
        • Ahmed H.E.
        • Proctor T.J.
        • et al.
        Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain.
        Diabetes Care. 2000; 23: 365-370
        • Altman D.G.
        • Schulz K.F.
        • Moher D.
        • Egger M.
        • Davidoff F.
        • Elbourne D.
        • et al.
        The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
        Ann. Intern. Med. 2001; 134: 663-694
        • Carroll D.
        • Moore R.A.
        • McQuay H.J.
        • Fairman F.
        • Tramèr M.
        • Leijon G.
        Transcutaneous electrical nerve stimulation (TENS) for chronic pain.
        Cochrane Database Syst. Rev. 2001; 3: CD003222
        • Jiang Y.X.
        • Wang Y.
        • Liu H.X.
        Comparison between therapeutic effects of transcutaneous electrical nerve stimulation with the frequency of 2 Hz and 100 Hz on chronic inflammatory pain in rats.
        Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001; 21: 923-925
        • Hamza M.A.
        • White P.F.
        • Ahmed H.E.
        • Ghoname E.A.
        Effect of the frequency of transcutaneous electrical nerve stimulation on the postoperative opioid analgesic requirement and recovery profile.
        Anesthesiology. 1999; 91: 1232-1238
        • Chesterton L.S.
        • Foster N.E.
        • Wright C.C.
        • Baxter G.D.
        • Barlas P.
        Effects of TENS frequency, intensity and stimulation site parameter manipulation on pressure pain thresholds in healthy human subjects.
        Pain. 2003; 106: 73-80
        • Law P.P.
        • Cheing G.L.
        Optimal stimulation frequency of transcutaneous electrical nerve stimulation on people with knee osteoarthritis.
        J. Rehabil. Med. 2004; 36: 220-225
        • Cameron N.E.
        • Cotter M.A.
        • Robertson S.
        Chronic low frequency electrical activation for one week corrects nerve conduction velocity deficits in rats with diabetes of three months duration.
        Diabetologia. 1989; 32: 759-761
        • Han J.S.
        • Chen X.H.
        • Sun S.L.
        • Xu X.J.
        • Yuan Y.
        • Yan S.C.
        • et al.
        Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF.
        Pain. 1991; 47: 295-298
        • Garrison D.W.
        • Foreman R.D.
        Effects of transcutaneous electrical nerve stimulation (TENS) on spontaneous and noxiously evoked dorsal horn cell activity in cats with transected spinal cords.
        Neurosci. Lett. 1996; 216: 125-128
        • de Tommaso M.
        • Fiore P.
        • Camporeale A.
        • Guido M.
        • Libro G.
        • Losito L.
        • et al.
        High and low frequency transcutaneous electrical nerve stimulation inhibits nociceptive responses induced by CO2 laser stimulation in humans.
        Neurosci. Lett. 2003; 342: 17-20
        • Julka I.S.
        • Alvaro M.
        • Kumar D.
        Beneficial effects of electrical stimulation on neuropathic symptoms in diabetes patients.
        J. Foot Ankle Surg. 1998; 37: 191-194
        • Deyo R.A.
        • Walsh N.E.
        • Martin D.C.
        • Schoenfeld L.S.
        • Ramamurthy S.
        A controlled trial of transcutaneous electrical nerve stimulation (TENS) and exercise for chronic low back pain.
        N. Engl. J. Med. 1990; 322: 1627-1634